Quantitative and qualitative assays for detection of tumor-associated markers using immunoassay technology. Supports oncology screening and monitoring applications in clinical laboratories.
Manufactured by
Hangzhou Zhejiang, China
Assure Tech. (Hangzhou) Co., Ltd. was established by senior experts of IVD industry in 2008. As a high-tech biotechnology company, Assure tech. owns an advanced level in several IVD areas, including Immunoassay Diagnostics, Biochemical Diagnostics, Coagulation Diagnostics, Molecular Diagnostics, Rapid Test, Chronic Disease Monitoring. We currently have established the R&D and manufacturing base, which delivers annual production capacity of hundreds of millions devices. What's more, we are committed to the R&D of the colloidal gold rapid detection reagents, laboratory equipment, and biological materials. Hundreds of products in the 9 series are successfully developed including Drug of Abuse Tests, Infectious Disease Tests, Hormone Tests, Tumor Markers Tests, Cardiac Markers Tests, Biochemical Tests, Allergy Tests, veterinary Diagnostics and Chronic Disease Series.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Fujirebio Diagnostics,Inc.
China · 3 relevant products
GESIM Gesellschaft für Silizium-Mikrosysteme mbH
Germany · 1 relevant product
Beijing Hotgen Biotech Co.,Ltd
China · 2 relevant products
Atom Scientific Ltd
United Kingdom · 1 relevant product
BEACON DIAGNOSTICS PVT. LTD.
India · 1 relevant product
AVE Science & Technology Co.,Ltd.
China · 2 relevant products
Sclavo Diagnostics International S.p.A.
Italy · 2 relevant products
Anbio Biotechnology Limited
Germany · 1 relevant product
Qassay
United States · 1 relevant product
Burning Rock Dx Co. Ltd.
China · 1 relevant product
67 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 100 closest product alternatives
Fujirebio Diagnostics,Inc. · China
Comprehensive in vitro diagnostic assays for tumor marker detection with simple experimental procedures and stable, accurate results. The product line provides reliable detection across multiple oncological markers for clinical laboratory use.
GESIM Gesellschaft für Silizium-Mikrosysteme mbH · Germany
Multiplexed microarray assay for simultaneous detection of multiple tumor markers in clinical samples. Enables comprehensive cancer biomarker profiling in a single test.
Beijing Hotgen Biotech Co.,Ltd · China
ELISA-based diagnostic kit for tumor marker detection and quantification. Supports cancer screening and monitoring in laboratory settings.
Atom Scientific Ltd · United Kingdom
Immunoassay systems for detecting cancer biomarkers in serum and plasma. Supports oncology screening and treatment monitoring applications.
BEACON DIAGNOSTICS PVT. LTD. · India
Immunoassay kits for measurement of various tumor markers in serum samples. Supports cancer screening, diagnosis, and surveillance.
AVE Science & Technology Co.,Ltd. · China
Reagent system for measuring tumor-associated antigens in patient samples. Supports cancer screening and treatment monitoring.
Sclavo Diagnostics International S.p.A. · Italy
Immunochemical systems for measurement of tumor-associated antigens including PSA, CEA, and AFP. Applied in cancer screening and monitoring applications.
Anbio Biotechnology Limited · Germany
Comprehensive testing suite for oncology biomarkers including CEA, AFP, and CA markers. Supports cancer diagnosis, prognosis, and treatment monitoring.
Qassay · United States
Assay for detecting and quantifying cancer-related biomarkers. Supports early detection and monitoring through rapid point-of-care testing.
Burning Rock Dx Co. Ltd. · China
Multiplex immunoassay platform for detecting circulating cancer biomarkers in blood samples. Facilitates early diagnosis and treatment response monitoring in oncology patients.
Beijing Zhongjian Antai Diagnostic Co., Ltd. · China
Diagnostic assay for measuring disease-specific biomarkers in patient samples. The assay supports diagnosis and monitoring of infectious conditions.
PlexBio Co., Ltd. · Taiwan
Comprehensive collection of molecular diagnostic assays for cancer detection and analysis. Includes advanced testing solutions for lung cancer and other oncological applications.
88 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products